Virtual screening of GPR37L1 small-molecule modulator for neuropathic pain
Abstract
Abstract: Accumulating evidence indicates that glial cells play a critical role in the initiation, maintenance, and resolution of neuropathic pain. However, there is lack of glia-specific molecular targets for pain management. We recently identified the G protein-coupled receptor GPR37-like 1 (GPR37L1) as a glia-selective receptor expressed in astrocytes and satellite glial cells (SGCs), and GPR37L1 protects against the development of neuropathic pain, highlighting it as a promising target for neuroglial modulation. Building on our discovery that the proresolving lipid mediator Maresin1 acts as an endogenous ligand for GPR37L1, this study aimed to identify small-molecule GPR37L1 agonists with improved synthetic accessibility and analgesic duration. Using virtual screening combined with molecular dynamics simulations, we identified compound P06 as a top candidate with the highest predicted binding affinity. In vitro, P06 induced a dose-dependent potassium influx in cells expressing GPR37L1. The analgesic efficacy of P06 was evaluated in mouse models of neuropathic pain after chemotherapy-induced peripheral neuropathy and spared nerve injury (SNI). A single intrathecal injection of P06 produced robust and long-lasting inhibition of chemotherapy-induced mechanical allodynia for more than 24 hours. This effect was completely abolished in Gpr37l1 knockout mice, confirming a receptor-dependent mechanism. P06 also alleviated SNI-induced mechanical/cold allodynia and mitigated nerve…
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.